Maturing Business Models Using Genomics Data

01 Jan 2001

• By Michael Lytton

Advice of Counsel addresses the question of whether genomics companies are using new business models and deal structures to commercialize their technologies.

Question:Now that genomic data is widely available, are genomics companies using new business models and deal structures to commercialize their technologies?

Answer:Yes, the emphasis has clearly shifted away from pure database or target identification deals to new paradigms. The shift has...